Bioregenx (BRGX) Long-Term Investments (2021 - 2023)

Bioregenx's Long-Term Investments history runs 3 years deep, the most recent figure standing at $100.0 for Q4 2023.

• On a quarterly basis, Long-Term Investments fell 99.52% year-over-year to $100.0 in Q4 2023; TTM through Dec 2023 was $100.0, a 99.52% decrease from a year earlier, with the FY2023 full-year figure at $100.0, down 99.52% from the prior year.
• Long-Term Investments declined to $100.0 in Q4 2023 per BRGX's latest filing, from $200.0 in the prior quarter.
• Across five years, Long-Term Investments topped out at $60000.0 in Q4 2021 and bottomed at $100.0 in Q4 2023.
• The 3-year median for Long-Term Investments is $31500.0 (2022), against an average of $29050.0.
• Across the five-year window, Long-Term Investments slumped 65.0% in 2022 and sank 99.52% in 2023, its largest moves.
• Year by year, Long-Term Investments stood at $60000.0 in 2021, then slumped by 65.0% to $21000.0 in 2022, then sank by 99.52% to $100.0 in 2023.
• Per Business Quant, the three latest BRGX Long-Term Investments figures stand at $100.0 (Q4 2023), $200.0 (Q3 2023), and $51000.0 (Q2 2023).